L-745,870
Systematic (IUPAC) name | |
---|---|
3-([4-(4-chlorophenyl)piperazin-1-yl]methyl)-1H-pyrrolo[2,3-b]pyridine | |
Identifiers | |
CAS Number | 158985-00-3 |
PubChem | CID 5311200 |
IUPHAR/BPS | 3303 |
ChemSpider | 4470720 |
ChEMBL | CHEMBL267014 |
Chemical data | |
Formula | C18H19ClN4 |
Molar mass | 326.822 g/mol |
| |
| |
(what is this?) (verify) |
L-745,870 is a drug which acts as a dopamine receptor antagonist selective for the D4 subtype, and has antipsychotic effects in animal models, though it was not effective in human trials.[1][2][3]
References
- ↑ Bristow LJ, Kramer MS, Kulagowski J, Patel S, Ragan CI, Seabrook GR (June 1997). "Schizophrenia and L-745,870, a novel dopamine D4 receptor antagonist". Trends in Pharmacological Sciences 18 (6): 186–8. doi:10.1016/s0165-6147(97)01066-3. PMID 9226994.
- ↑ Zhang K, Grady CJ, Tsapakis EM, Andersen SL, Tarazi FI, Baldessarini RJ (September 2004). "Regulation of working memory by dopamine D4 receptor in rats". Neuropsychopharmacology 29 (9): 1648–55. doi:10.1038/sj.npp.1300491. PMID 15138447.
- ↑ Moustgaard A, Hau J, Lind NM (2008). "Effects of dopamine D4 receptor antagonist on spontaneous alternation in rats". Behavioral and Brain Functions 4: 49. doi:10.1186/1744-9081-4-49. PMC 2577092. PMID 18945334.
This article is issued from Wikipedia - version of the Wednesday, January 27, 2016. The text is available under the Creative Commons Attribution/Share Alike but additional terms may apply for the media files.